Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
SamaCare Welcomes Komodo Health CEO Arif Nathoo to Board of Directors
SamaCare, a prior authorization platform for physician-administered medications, is excited to announce the addition of […]
Heron Therapeutics Announces New CEO and Board Chairman
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
Wyss Center Geneva Appoints Erwin Böttinger as New Chief Executive Officer
The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, […]
SynAct Pharma Appoints Torbjørn Bjerke as New CEO
SynAct Pharma has announced the appointment of the company’s current Chairman Torbjørn Bjerke MD, as […]
Celyad Oncology Appoints Georges Rawadi as Its New CEO
Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]
Morphimmune Appoints Dr. Clay Siegall Chief Executive Officer and President
Morphimmune, a preclinical biotechnology company focused on developing targeted oncology therapeutics, today announced the appointment […]
Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO
Semler Scientific, a company that provides technology solutions to improve the clinical effectiveness and efficiency […]
Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth
Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral […]
Charter Healthcare Names New CEO and COO
Charter Healthcare, the post-acute provider platform of Pharos Capital Group, LLC, announced today that it […]
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company focused on therapies for cardiometabolic diseases, today announced that it […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more